A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants with Advanced Solid Tumors (MK-3120-002)

Trial Identifier:	3120-002
Sponsor:	MSD
Start Date:	March 2025
Primary Completion Date:	January 2028
Study Completion Date:	January 2028
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	Protocol Plain Language Summary – English

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.